Study Details
A Study to Evaluate the Safety and Effectiveness of Injectable Disc Cell Therapy for Patients Who Have Mild to Moderate Lumbar Disc Degeneration
(IRB#: IRB_00194600)
The purpose of this research is to find out if the experimental drug, Injectable Disc Cell Therapy (IDCT), is safe and effective in treating symptomatic lumbar degenerative disc disease.
- All genders
- Over 18 years old
- Volunteers with special conditions
- In Person
- Paid
Who can participate?
Gender: All genders
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria
- Is 18 up to 75 years of age
- Has been diagnosed with mild to moderate degenerative disc disease in the lower back
- Has been experiencing chronic low back pain for at least 6 months before the screening visit.
- Conservative treatment hasn't been working for the low back pain for at least 3 months. Conservative treatment includes such treatments as seeing a chiropractor, massage therapy, physical therapy and acupuncture. AND Conservative treatment with medications such as acetaminophen, ibuprofen, duloxetine or back injections aren't effective in treating the low back pain.
- Willing to sign the study consent form.
Exclusion Criteria
- Has leg pain that is worse than the low back pain
- Has had lower back surgery
- Has been diagnosed with fibromyalgia
- Can't have an MRI because of a pacemaker or similar device, or because the test can't be tolerated.
- Has an autoimmune disease such as rheumatoid arthritis
Will I be paid for my time?
Yes
IRB#: IRB_00194600
PI: Zachary McCormick
Department: Physical Medicine and Rehabilitation
Approval Date: 2026-02-18 07:00:00
Study Categories: Bone and Muscle Studies
Specialties: Physical Medicine & Rehabilitation
I am Interested